Anaphylaxis Treatment Market Report 2025 (Global Edition)

Global Anaphylaxis Treatment Market Report 2025 Market Size Split by Medication Type (Epinephrine, Antihistamines, Steroids, Beta-Agonist, Others), by Route of Administration (Oral, Parenteral, Others...

Anaphylaxis Treatment Market Report Description

We have various report editions of Anaphylaxis Treatment Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Anaphylaxis Treatment Market Insights Video

Competitive Landscape of the Anaphylaxis Treatment Market

The competitive landscape of the Anaphylaxis Treatment market is characterized by a diverse range of players competing to gain market share through product innovation, strategic partnerships, and aggressive marketing efforts. Key players in the market include established electronics manufacturers, specialized Anaphylaxis Treatment companies, and emerging start-ups aiming to disrupt the market with innovative solutions.

March 2023: Aquestive Therapeutics Inc. reported that AQST-109, the first orally given epinephrine-based medication for the emergency treatment of allergic reactions, has been approved by the US FDA. (Source: https://aquestive.com/aquestive-therapeutics-receives-fda-fast-track-designation-for-aqst-109-for-emergency-treatment-of-allergic-reactions-including-anaphylaxis/s)

Top Companies Market Share in Anaphylaxis Treatment Industry: (In no particular order of Rank)

• Pfizer Inc.
• Mylan N.V
• GlaxoSmithKline Plc
• Amneal Pharmaceuticals
• Merck & Co Inc
• Teva Pharmaceutical Industries ltd.
• Adamis Pharmaceutical Corporation
• Abbott Laboratories
• Sandoz Inc.
• Aquestive Therapeutics Inc.
• Amphastar Pharmaceuticals Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Anaphylaxis Treatment Market

Which Region Dominates the Anaphylaxis Treatment Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue. North America's Anaphylaxis Treatment Market is increasing because of the accelerated occurrence of allergic reactions and rising recognition of anaphylaxis. The place advantages from superior healthcare infrastructure and sturdy regulatory surroundings, fostering innovation and market growth. With a focus on enhancing admission to emergency medicines like epinephrine automobile injectors, North America leads in addressing the desires of people liable to excessive allergies.

Which Region is Expanding at the Fastest CAGR?

Europe stands out as the fastest-growing region in the Anaphylaxis Treatment market due to several compelling reasons. ? Europe's Anaphylaxis Treatment Market is witnessing an increase driven by growing hypersensitive reaction incidence and heightened consciousness of anaphylactic reactions. The place's strong healthcare infrastructure and emphasis on affected person protection contribute to marketplace enlargement. Increased funding in studies and development, coupled with regulatory aid, fosters innovation in emergency medications like epinephrine automobile injectors. Europe continues to steer in offering powerful treatments for dealing with and stopping intense allergies.

 

The current report Scope analyzes Anaphylaxis Treatment Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Anaphylaxis Treatment

According to Cognitive Market Research, the global Anaphylaxis Treatment market size was estimated at USD 2841.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 1136.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Anaphylaxis Treatment market with a market size of USD 896.68 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. The demand is amplified by the allergen exposure increase.
• The Canada Anaphylaxis Treatment market had a market share of USD 136.38 million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period. Canada's improved diagnostics.
• The Mexico Anaphylaxis Treatment market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 103.42 million in 2024.

Europe Anaphylaxis Treatment

According to Cognitive Market Research, the global Anaphylaxis Treatment market size was estimated at USD 2841.2 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 852.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.

• The United Kingdom Anaphylaxis Treatment market had a market share of USD 143.20 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. In the UK, Anaphylaxis Treatment sales witness an upswing due to the awareness campaigns.
• The France Anaphylaxis Treatment market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 78.42 million in 2024.
• According to Cognitive Market Research, the Germany Anaphylaxis Treatment market size was valued at USD 168.77 million in 2024 and is projected to grow at a CAGR of 7.7% during the forecast period. In Germany, Anaphylaxis Treatment sales surged due to the healthcare infrastructure development.
• The Italy Anaphylaxis Treatment market is projected to witness growth at a CAGR of 6.9% during the forecast period, with a market size of USD 73.30 million in 2024.
• The Russia Anaphylaxis Treatment market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 132.12 million in 2024.
• The Spain Anaphylaxis Treatment market is projected to witness growth at a CAGR of 6.6% during the forecast period with a market size of USD 69.89 million in 2024
• The Luxembourg Anaphylaxis Treatment market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 26.42 million in 2024.
• The Portugal Anaphylaxis Treatment market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 17.90 million in 2024.
• The Greece Anaphylaxis Treatment market is projected to witness growth at a CAGR of 7.8% during the forecast period, with a market size of USD 10.23 million in 2024.
• Rest of Europe's Anaphylaxis Treatment market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 132.12 million in 2024.

Asia Pacific Anaphylaxis Treatment

According to Cognitive Market Research, the global Anaphylaxis Treatment market size was estimated at USD 2841.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 653.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Anaphylaxis Treatment market size was valued at USD 294.06 million in 2024 and is projected to grow at a CAGR of 10.5% during the forecast period. Anaphylaxis Treatment sales surge in China due to the regulatory support.
• The Japan Anaphylaxis Treatment market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 90.18 million in 2024.
• The India Anaphylaxis Treatment market had a market share of USD 78.42 million in 2024 and is projected to grow at a CAGR of 12.8% during the forecast period. India's technological advancements.
• The South Korea Anaphylaxis Treatment market is projected to witness growth at a CAGR of 10.1% during the forecast period, with a market size of USD 65.35 million in 2024.
• The Australia Anaphylaxis Treatment market is projected to witness growth at a CAGR of 10.7% during the forecast period, with a market size of USD 33.98 million in 2024.
• The South East Asia Anaphylaxis Treatment market is projected to witness growth at a CAGR of 12.0% during the forecast period, with a market size of USD 45.09 million in 2024.
• The Rest of Asia Pacific Anaphylaxis Treatment market is projected to witness growth at a CAGR of 10.8% during the forecast period, with a market size of USD 46.40 million in 2024.

South America Anaphylaxis Treatment

According to Cognitive Market Research, the global Anaphylaxis Treatment market size was estimated at USD 2841.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 142.06 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Anaphylaxis Treatment market size was valued at USD 60.80 million in 2024 and is projected to grow at a CAGR of 9.0% during the forecast period. Anaphylaxis Treatment sales flourish in Brazil due to the patient education.
• Argentina Anaphylaxis Treatment market had a market share of USD 23.87 million in 2024 and is projected to grow at a CAGR of 9.3% during the forecast period. Argentina's emergency preparedness.
• Colombia Anaphylaxis Treatment market is projected to witness growth at a CAGR of 8.2% during the forecast period with a market size of USD 12.64 million in 2024.
• Peru Anaphylaxis Treatment market is projected to witness growth at a CAGR of 8.6% during the forecast period with a market size of USD 11.65 million in 2024.
• Chile Anaphylaxis Treatment market is projected to witness growth at a CAGR of 8.7% during the forecast period with a market size of USD 10.23 million in 2024.
• The Rest of Latin America Anaphylaxis Treatment market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 22.87 million in 2024.

Middle East and Africa Anaphylaxis Treatment

According to Cognitive Market Research, the global Anaphylaxis Treatment market size was estimated at USD 2841.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 56.82 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2031.

• The GCC Countries Anaphylaxis Treatment market is projected to witness growth at a CAGR of 9.5% during the forecast period with a market size of USD 24.32 million in 2024. Anaphylaxis Treatment sales flourish due to the research funding.
• The Egypt Anaphylaxis Treatment market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 5.97 million in 2024.
• The South Africa Anaphylaxis Treatment market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 8.98 million in 2024. Anaphylaxis Treatment sales flourish in South Africa due to the drug innovation.
• The Turkey Anaphylaxis Treatment market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 4.89 million in 2024.
• The Nigeria Anaphylaxis Treatment market is projected to witness growth at a CAGR of 7.8% during the forecast period, with a market size of USD 5.97 million in 2024.
• The Rest of MEA Anaphylaxis Treatment market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 6.71 million in 2024.

Anaphylaxis Treatment Market Analysis

Anaphylaxis Treatment Market Medication Type Segment Analysis

According to Cognitive Market Research, Epinephrine stands out as the dominating category. Epinephrine is a key driving force of increase in the Anaphylaxis Treatment Market due to its critical position in coping with severe hypersensitive reactions. The increasing incidence of allergic reactions and rising consciousness of anaphylaxis have propelled the call for epinephrine car injectors. With the emphasis on active remedy and accessibility, epinephrine remains a cornerstone therapy, contributing significantly to the expansion of the anaphylaxis treatment marketplace.

Antihistamines emerges as the fastest-growing category in the Anaphylaxis Treatment market. Antihistamines are contributing to the growth of the Anaphylaxis Treatment Market because of their function in dealing with allergic reactions. As the prevalence of allergic reactions rises and awareness of anaphylaxis increases, the call for antihistamines as a complementary treatment along with epinephrine automobile injectors grows. Their capacity to relieve symptoms, which include itching, hives, and swelling, reinforces their importance in the control of anaphylactic reactions using marketplace expansion.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Anaphylaxis Treatment Industry. Request a Free Sample PDF!

Anaphylaxis Treatment Market Route of Administration Segment Analysis

According to Cognitive Market Research, the dominating category is Oral. Oral medicines are riding growth within the Anaphylaxis Treatment Market as they offer handy and powerful options for dealing with allergies. With improvements in formula and transport, oral remedies consisting of antihistamines and corticosteroids provide speedy alleviation for slight to slight symptoms of anaphylaxis. The growing availability and efficacy of oral medications make contributions to their growing prominence in anaphylaxis control, fueling marketplace enlargement.

The fastest-growing category in the Anaphylaxis Treatment market is Integrated. Parenteral medicines, administered through injection or infusion, are riding increase within the Anaphylaxis Treatment Market because of their fast onset of motion and efficacy in handling severe allergies. With the increasing prevalence of allergic reactions and cognizance of anaphylaxis, parenteral treatments like epinephrine car-injectors play a vital position in providing instant alleviation and preventing life-threatening complications, contributing appreciably to marketplace expansion.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Anaphylaxis Treatment Allergy Type Segment Analysis

Allergy Type Segment Analysis

According to Cognitive Market Research, the dominating category is Food Allergy. The increasing incidence of meal allergies is driving an increase in the Anaphylaxis Treatment Market because it heightens the risk of extreme allergies and anaphylaxis. With a growing focus on meal hypersensitive reactions and the significance of early intervention, there is a growing call for effective remedies such as epinephrine vehicle injectors and antihistamines to control and prevent anaphylactic reactions, fostering market growth.

The fastest-growing category in the Anaphylaxis Treatment market is Medications. Medications are pivotal in using the boom in the Anaphylaxis Treatment Market, imparting numerous alternatives for managing extreme hypersensitive reactions. Epinephrine vehicle injectors, antihistamines, corticosteroids, and immunomodulators are among the key medications used to relieve signs and prevent life-threatening complications. With increasing awareness of anaphylaxis and the importance of set-off treatment, the call for powerful medicines continues to develop, fueling market enlargement.

• Food Allergy
• Medications
• Insect Stings
• Others

Anaphylaxis Treatment Distribution Channel Segment Analysis

Distribution Channel Segment Analysis

According to Cognitive Market Research, the dominating category is Hospital Pharmacies. Hospital pharmacies are contributing to the growth of the Anaphylaxis Treatment Market by way of providing convenient admission to to emergency medications and ensuring their availability in healthcare settings. With hospitals being the primary factor in taking care of severe allergies, the demand for medications, including epinephrine automobile injectors, is increasing. Hospital pharmacies play an important role in assembly this demand and driving market enlargement.

The fastest-growing category in the Anaphylaxis Treatment market is Retail Sales. Retail sales are driving a boom within the Anaphylaxis Treatment Market by means of increasing get right of entry to to emergency medications in network settings. With the increasing prevalence of hypersensitive reactions and focus on anaphylaxis, retail outlets play a critical position in providing handy entry to medicinal drugs like epinephrine auto-injectors. As more people are trying to manage allergic reactions efficiently, retail sales contribute substantially to marketplace enlargement and accessibility.

• Hospital Pharmacies
• Retail Sales
• Others

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion